Rep. Katie Porter

@RepKatiePorter ↗

Deleted No

Hibernated No

Last Checked Jan. 3, 2020

Created

Sat Oct 12 17:29:09 +0000 2019

Likes

242

Retweets

Source

Twitter for iPhone

View Raw Data

JSON Data

View on Twitter

Likely Available

Rep. Katie Porter @RepKatiePorter

From 2006-2015, Big Pharma spent $465 billion on research and development. In that same time period, drug companies spent $516 billion to buy back their own stock from shareholders. These buybacks mostly enrich the already wealthy—like CEOs. (4/6) — PolitiTweet.org

Posted Oct. 12, 2019

Preceded By

Rep. Katie Porter @RepKatiePorter

Big Pharma likes to say they “need” money from price hikes to research new cures. This work is important, but it’s not the full story. (3/6) — PolitiTweet.org

Posted Oct. 12, 2019

Followed By

Rep. Katie Porter @RepKatiePorter

And did Big Pharma use the tax cuts they received in the Trump tax law for research and development? Of course not. These companies have made $73 billion in buybacks from the Trump tax law, far more than some have spent on research and development. (5/6) https://t.co/7VBpFFJKUx — PolitiTweet.org

Posted Oct. 12, 2019